澳大利亚糖尿病数据网络中7961例儿童及年轻成人1型糖尿病确诊时糖尿病酮症酸中毒与长期HbA1c的关系
研究纳入2000至2019年确诊的7961例30岁前发病的1型糖尿病患儿及年轻成人,随访至2020年12月31日。确诊时重度糖尿病酮症酸中毒(DKA)与长期平均HbA1c轻度升高相关(+0.23%),使用持续皮下胰岛素输注(CSII)与较低HbA1c独立相关(-0.28%),原住民身份和较低社会经济地位与较高HbA1c独立相关。
要点
- 确诊时33.2%存在DKA,仅重度DKA与随访期平均HbA1c升高相关(+0.23%)。
- 使用CSII与平均HbA1c降低独立相关(-0.28%),并与重度DKA交互降低预测HbA1c。
- 原住民身份和社会经济地位较低与长期HbA1c较高独立相关。
核心结论
- 确诊时重度而非轻度或中度DKA与随访期HbA1c轻度升高相关,该效应受CSII使用影响。
- 原住民身份和较低社会经济地位与长期HbA1c较高独立相关。
研究设计与样本
- 前瞻性队列研究,纳入2000至2019年确诊且年龄≤30岁的7961例1型糖尿病患儿及年轻成人,随访至2020年12月31日。
- 采用线性混合效应模型分析变量与HbA1c的关系。
主要发现
- 确诊时DKA存在于2647例参与者(33.2%)。
- 中位随访5.6年(四分位距3.2,9.4)期间,重度DKA者平均HbA1c较无DKA者高0.23%(95%CI 0.11,0.28;[+2.5 mmol/mol,95%CI 1.4,3.6];P<0.001),轻中度DKA者无此差异。
- 使用CSII者HbA1c较每日多次注射者低0.28%(95%CI -0.31,-0.25;[-3.1 mmol/mol,95%CI -3.4,-2.8];P<0.001),CSII使用与重度DKA交互降低预测HbA1c。
- 原住民身份者HbA1c较高(+1.37%,95%CI 1.15,1.59;[+15.0 mmol/mol,95%CI 12.6,17.4];P<0.001)。
- 居住于社会经济地位较低邮编者HbA1c较高(最劣势五分位 vs 最优势五分位 +0.43%,95%CI 0.34,0.52;[+4.7 mmol/mol,95%CI 3.4,5.6];P<0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The relationship between diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes and long-term glycemic control varies between studies. We aimed, firstly, to characterize the association of DKA and its severity with long-term HbA1c in a large contemporary cohort, and secondly, to identify other independent determinants of long-term HbA1c. RESEARCH DESIGN AND METHODS: Participants were 7,961 children and young adults diagnosed with type 1 diabetes by age 30 years from 2000 to 2019 and followed prospectively in the Australasian Diabetes Data Network (ADDN) until 31 December 2020. Linear mixed-effect models related variables to HbA1c. RESULTS: DKA at diagnosis was present in 2,647 participants (33.2%). Over a median 5.6 (interquartile range 3.2, 9.4) years of follow-up, participants with severe, but not moderate or mild, DKA at diagnosis had a higher mean HbA1c (+0.23%, 95% CI 0.11,0.28; [+2.5 mmol/mol, 95% CI 1.4,3.6]; P < 0.001) compared with those without DKA. Use of continuous subcutaneous insulin infusion (CSII) was independently associated with a lower HbA1c (-0.28%, 95% CI -0.31, -0.25; [-3.1 mmol/mol, 95% CI -3.4, -2.8]; P < 0.001) than multiple daily injections, and CSII use interacted with severe DKA to lower predicted HbA1c. Indigenous status was associated with higher HbA1c (+1.37%, 95% CI 1.15, 1.59; [+15.0 mmol/mol, 95% CI 12.6, 17.4]; P < 0.001), as was residing in postcodes of lower socioeconomic status (most vs. least disadvantaged quintile +0.43%, 95% CI 0.34, 0.52; [+4.7 mmol/mol, 95% CI 3.4, 5.6]; P < 0.001). CONCLUSIONS: Severe, but not mild or moderate, DKA at diagnosis was associated with a marginally higher HbA1c over time, an effect that was modified by use of CSII. Indigenous status and lower socioeconomic status were independently associated with higher long-term HbA1c.
引用
- Clapin HF, Earnest A, Colman PG, et al. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network. Diabetes Care. 2022. PMID: 36749868. doi:10.2337/dc22-0853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。